Is It Time To Reassess Nuvation Bio (NUVB) After Its Recent Share Price Surge?
- Wondering whether Nuvation Bio at around US$5.04 is offering genuine value or just riding on excitement? This article breaks down what the current share price may be implying about the business.
- The stock has returned 4.8% over the last 7 days and 17.8% over the last 30 days, while year to date it is down 41.3% and the 1 year return sits at 136.6%, with a 3 year return of 217.0% and a 5 year return of 56.5%.
- Recent price action has come alongside ongoing interest in the company’s drug development pipeline and progress updates in its core oncology programs. These developments give investors more information to weigh against the share price moves that have already taken place.
- Nuvation Bio currently has a valuation score of 2 out of 6….
Source link
